FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 8, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 8, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 33.7% of total US population have received at least 1 dose
• 19.9% of total US population are fully vaccinated
• 19.9% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. New Mexico: 27.2%
2. Rhode Island: 26%
3. South Dakota 26%
4. Alaska: 25.5%
5. Maine: 25.1%
2. Rhode Island: 26%
3. South Dakota 26%
4. Alaska: 25.5%
5. Maine: 25.1%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 30 949 994 confirmed cases
• 559 494 deaths
• 559 494 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 687 988
2. Texas: 2 815 932
3. Florida: 2 096 747
4. New York: 1 928 650
5. Illinois: 1 269 078
2. Texas: 2 815 932
3. Florida: 2 096 747
4. New York: 1 928 650
5. Illinois: 1 269 078
Deaths: California has the most deaths due to COVID-19 with 60 038 reported fatalities, followed by New York with 50 886, and Texas with 48 932.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 133 389 772 confirmed cases, 2 892 713 deaths, and 75 894 911 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
Advertisement
Advertisement
Trending on Patient Care Online
1
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
2
FDA Grants Priority Review to Elinzanetant for VMS in HR+ Breast Cancer Patients on Endocrine Therapy
3
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
4
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
5